Budde, E., Real, M. D., Baird, J., Chen, L., Song, J., Wang, X., Thiruvengadam, S., Hu, M., Macias, A., Marcucci, E., Cha, S., Dong, Z., Kim, T., Barva, B., Puverel, S., Liu-Michael, Q., Cheng, H. (., Forman, S., Kwak, L. (2025). BAFFR-CAR T cells (PMB-CT01) demonstrate durable responses and manageable toxicities in relapsed/refractory B-cell lymphomas with prior CD19-directed therapy failure or CD19-negative disease. Blood. https://doi.org/10.1182/blood-2025-268